Article
Association of emergence of new mutations in circulating tumuor DNA during chemotherapy with clinical outcome in metastatic colorectal cancer.
BMC cancer - 22 Jul 2021
Jia Ning, Chang Lianpeng, Gao Xin, Shi Xiaohua, Dou Xuelin, Guan Mei, Shao Yajuan, Li Ningning, Cheng Yuejuan, Ying Hongyan, Sun Zhao, Zhou Yanping, Zhao Lin, Zhou Jianfeng, Bai Chunmei
Abstract excerpt
BACKGROUND: The understanding of molecular changes in mCRC during treatment could be used to personalise therapeutic strategies. The aim of our study was to explore the association of circulating tumour DNA (ctDNA) with clinical outcome in metastatic colorectal cancer (mCRC). METHODS: Sequential patients with mCRC receiving standard first-line chemotherapy were included prospectively. Both plasma ctDNA and serum...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
